Perrigo | PRGO - Прибыль до налогообложения





Прибыль до налогообложения Изменить Дата
AbbVie USD 7.87B 253M 2026-09
Abbott USD 2.92B 535M 2026-09
Bayer EUR 321M 2.67B 2026-06
Bristol-Myers Squibb USD 4.99B 1.75B 2026-06
Coherus Biosciences USD -46.35M 90.86M 2025-12
Corcept Therapeutics USD 45.93M 90.65M 2026-06
Dr.Reddys Laboratories INR 5.54B 955M 2026-06
Eli Lilly USD 8.79B 457M 2026-09
J&J USD 7.67B 988M 2026-09
Merck USD -683M 2.85B 2026-06
Nestle CHF 6.77B 475M 2026-06
Pacira USD 2.55M 2.44M 2026-06
Perrigo USD -18.1M 123.5M 2026-09
Pfizer USD 3.38B 4.04B 2026-09
Phibro Animal Health USD 38.62M 1.26M 2025-12
Prestige Brands USD 38.54M 26.23M 2026-06
Reckitt Benckiser GBP 1.54B 73M 2025-06
Sanofi EUR 5.28B 4.44B 2026-09
Supernus Pharmaceuticals USD 22.71M 80.36M 2026-09
Teva Pharmaceutical Industries USD 300M 755M 2026-09
Xeris Pharmaceuticals USD -31.1M 33.34M 2026-06
Zoetis USD 866M 108M 2026-06